Laurie J. Hall Trustee’s Myriad Genetics MYGN Stock Holding History

Laurie J. Hall Trustee’s Portfolio MYGN Stock Details MYGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q4	$5K	Buy	200 +40	+25%	+$1.1K	﹤0.01%	296
2019 Q3	$5K	Hold	160	–	–	﹤0.01%	287
2019 Q2	$4K	Hold	160	–	–	﹤0.01%	305
2019 Q1	$5K	Hold	160	–	–	﹤0.01%	301
2018 Q4	$5K	Sell	160 -40	-20%	-$1.44K	﹤0.01%	303
2018 Q3	$9K	Hold	200	–	–	﹤0.01%	303
2018 Q2	$7K	Hold	200	–	–	﹤0.01%	312
2018 Q1	$6K	Hold	200	–	–	﹤0.01%	315
2017 Q4	$7K	Sell	200 -100	-33%	-$3.37K	﹤0.01%	316
2017 Q3	$10.9K	Hold	300	–	–	0.01%	250
2017 Q2	$7.75K	Hold	300	–	–	0.01%	265
2017 Q1	$5.55K	Hold	300	–	–	﹤0.01%	273
2016 Q4	$5K	Buy	+300	New	+$5.43K	﹤0.01%	273
2016 Q2	$10K	Buy	300 +160	+114%	+$5.56K	0.01%	236
2016 Q1	$5K	Buy	+140	New	+$5.28K	﹤0.01%	243

Other funds holding MYGN

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

EARNEST Partners Atlanta, Georgia $24.3B AUM 34.41% 1-Year Est. Return

GCM

Glenview Capital Management New York $3.98B AUM 20.52% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

DGI

Disciplined Growth Investors Minneapolis, Minnesota $4.89B AUM 33.85% 1-Year Est. Return

Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return

Laurie J. Hall Trustee's MYGN Position: Q4 2019 in Review

Laurie J. Hall Trustee increased its Myriad Genetics (MYGN) stake by 25% in Q4 2019, buying an estimated $1.1K and bringing the position to 200 shares worth $5K. The position accounts for ﹤0.01% of the portfolio, ranked #296.

Laurie J. Hall Trustee first reported a position in MYGN in Q1 2016 and has held it in 15 quarters since. The position peaked at $10.9K in Q3 2017. 227 funds tracked by Wall St. Rank hold MYGN as of Q4 2019.

Laurie J. Hall Trustee held 200 shares of Myriad Genetics worth $5K as of Q4 2019.
Laurie J. Hall Trustee bought 40 Myriad Genetics shares in Q4 2019, an estimated $1.1K.
Myriad Genetics made up ﹤0.01% of Laurie J. Hall Trustee's portfolio in Q4 2019, its #296 holding.
Laurie J. Hall Trustee first reported a position in Myriad Genetics in Q1 2016 and has held it in 15 quarters since.
Laurie J. Hall Trustee's Myriad Genetics position peaked at $10.9K in Q3 2017.
227 funds tracked by Wall St. Rank held Myriad Genetics as of Q4 2019.

Based on Laurie J. Hall Trustee's 13F filing for Q4 2019, filed 12 Feb 2020.